Helix Biopharma Corp. to Present at RHK Capital Conference in New York
24 juil. 2019 17h05 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer
09 juil. 2019 07h30 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 09, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results
11 juin 2019 07h33 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates...
Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm
30 mai 2019 17h48 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes Private Placement
29 mai 2019 18h22 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
L-DOS47 Phase II Randomized Study Advances to Second Cohort
01 mai 2019 08h08 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 01, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes Second Tranche of Private Placement
29 avr. 2019 18h54 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes First Tranche of Private Placement
18 avr. 2019 17h05 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 18, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Retains U.S. Legal and Capital Firms to Advise on U.S. Listing
17 avr. 2019 17h19 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 17, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Reports Voting Results
15 avr. 2019 22h14 HE
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...